Grafa News and Videos — Page 700

The Albanese Government has launched a review into Australia’s corporate and tax whistleblowing frameworks.

The Australian Competition and Consumer Commission has escalated its scrutiny of Peter Warren Automotive's (ASX:PWR) proposed acquisition of Wakeling Automotive Group.

Karyopharm Therapeutics (NASDAQ:KPTI) announced that its late-breaking Phase 3 SENTRY clinical trial data has been selected for an oral presentation at the European Hematology Association (EHA) 2026 Congress, placing the treatment among the top six late-breaking abstracts at the event.

Quantum Corp. (NASDAQ:QMCO) announced select preliminary, unaudited financial results for its fiscal fourth quarter of 2026, highlighted by total revenue that is expected to come in significantly ahead of the company's previously issued guidance range.

INVO Fertility (NASDAQ:IVF) reported a 5% increase in total net revenue for fiscal year 2025, supported by steady expansion across its clinic network and a restructured balance sheet that eliminated several complex legacy equity liabilities.

Cumberland Pharmaceuticals (NASDAQ:CPIX) and Vanderbilt Health announced that a Phase 2a clinical trial evaluating the investigational drug ifetroban successfully met its primary endpoint, demonstrating safety and tolerability in patients with high-risk solid tumors.

Castor Maritime (NASDAQ:CTRM) reported a significant turnaround in its financial performance for the first quarter of 2026, driven by steady operational growth and substantial non-operating gains from its investment holdings.

Legend Biotech (NASDAQ:LEGN) announced encouraging initial clinical data from an ongoing Phase 1 study evaluating LB2501, its experimental in vivo CD19/CD20 dual-targeting CAR-T therapy, for the treatment of patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

The Buckle (NYSE:BKE) announced that its Board of Directors has authorized a quarterly cash dividend of $0.35 per share, sustaining the retail company's program of regular distributions to its public investors.

Voyager Technologies (NYSE:VOYG) has signed a definitive agreement to acquire Astrobotic Technology, a privately held developer of commercial lunar delivery systems, surface power infrastructure, and reusable rockets.